{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:22:40Z","timestamp":1791235360583,"version":"4.1.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"Background<\/jats:title>Pompe disease (PD) is a rare, progressive autosomal recessive lysosomal storage disorder that directly impacts mitochondrial function, leading to structural abnormalities and potentially culminating in heart failure or cardiogenic shock. The clinical course and molecular mechanisms of the disease remain incompletely understood.<\/jats:p><\/jats:sec>Methods<\/jats:title>We performed a retrospective analysis to examine the clinical manifestations, genetic traits, and the relationship between PD and mitochondrial function in a pediatric patient. This comprehensive evaluation included the use of ultrasound echocardiograms, computed tomography (CT) scans, electrocardiograms, mutagenesis analysis, and structural analysis to gain insights into the patient's condition and the underlying mechanisms of PD. For structural analysis and visualization, the structure of protein data bank ID 5KZX of human GAA was used, and VMD software was used for visualization and analysis.<\/jats:p><\/jats:sec>Results<\/jats:title>The study revealed that a 5-month-old male infant was admitted due to fever, with physical examination finding abnormal cardiopulmonary function and hepatomegaly. Laboratory tests and echocardiography confirmed heart failure and hypertrophic cardiomyopathy. Despite a week of treatment, which normalized body temperature and reduced pulmonary inflammation, cardiac abnormalities did not show significant improvement. Further genetic testing identified a homozygous mutation c.2662G&gt;T (p.E888) in the GAA gene, leading to a diagnosis of Infantile-Onset Pompe Disease (IOPD).<\/jats:p><\/jats:sec>Conclusions<\/jats:title>Although enzyme replacement therapy can significantly improve the quality of life for patients with PD, enhancing mitochondrial function may represent a new therapeutic strategy for treating PD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1367108","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T05:00:21Z","timestamp":1708405221000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Interplay between mitochondrial dysfunction and lysosomal storage: challenges in genetic metabolic muscle diseases with a focus on infantile onset Pompe disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Mengjiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiechao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s12035-019-01820-5","article-title":"Molecular approaches for the treatment of Pompe disease","volume":"57","author":"Bellotti","year":"2020","journal-title":"Mol Neurobiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/15548627.2015.1009779","article-title":"Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease","volume":"11","author":"Lim","year":"2015","journal-title":"Autophagy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1874467212666190723144006","article-title":"Diazoxide modulates cardiac hypertrophy by targeting h2o2 generation and mitochondrial superoxide dismutase activity","volume":"13","author":"Lucas","year":"2020","journal-title":"Curr Mol Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e9186","DOI":"10.1097\/MD.0000000000009186","article-title":"Infantile-onset Pompe disease with neonatal debut","volume":"96","author":"Mart\u00ednez","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13023-023-02848-6","article-title":"Genotype, phenotype and treatment outcomes of 17 Malaysian patients with infantile-onset Pompe disease and the identification of 3 novel gaa variants","volume":"18","author":"Chan","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.34172\/bi.2022.23467","article-title":"To detect potential pathways and target genes in infantile Pompe patients using computational analysis","volume":"12","author":"Karada\u011f","year":"2022","journal-title":"Bioimpacts"},{"key":"B8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/ijns6020031","article-title":"Newborn screening for Pompe disease","volume":"6","author":"Sawada","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.839263","article-title":"Case report: identification of compound heterozygous mutations in a patient with late-onset glycogen storage disease type ii (Pompe disease)","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1055\/a-1110-7335","article-title":"Diagnosis and care of infants and children with Pompe disease","author":"Hahn","year":"2020","journal-title":"Klin Padiatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nmd.2020.10.009","article-title":"Cardiovascular disease in non-classic Pompe disease: a systematic review","volume":"31","author":"van Kooten","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12968-016-0311-9","article-title":"Pattern and prognostic value of cardiac involvement in patients with late-onset Pompe disease: a comprehensive cardiovascular magnetic resonance approach","volume":"18","author":"Boentert","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-014-0141-2","article-title":"Clinical and gaa gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238g>c as the most common mutation","volume":"15","author":"Liu","year":"2014","journal-title":"BMC Med Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/s41467-017-01263-3","article-title":"Structure of human lysosomal acid \u03b1-glucosidase-a guide for the treatment of Pompe disease","volume":"8","author":"Roig-Zamboni","year":"2017","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6780","DOI":"10.1074\/jbc.M404008200","article-title":"Lysosomal acid alpha-glucosidase consists of four different peptides processed from a single chain precursor","volume":"280","author":"Moreland","year":"2005","journal-title":"J Biol Chem"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1038\/mt.2012.152","article-title":"Pharmacological enhancement of \u03b1-glucosidase by the allosteric chaperone n-acetylcysteine","volume":"20","author":"Porto","year":"2012","journal-title":"Mol Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e13573","DOI":"10.1111\/cpr.13573","article-title":"Mitochondrial dysfunction is associated with hypertrophic cardiomyopathy in Pompe disease\u2014specific induced pluripotent stem cell-derived cardiomyocytes","author":"Huang","year":"2023","journal-title":"Cell Prolif"},{"key":"B18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1590\/0004-282X20150194","article-title":"Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease","volume":"74","author":"Llerena","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1017\/cjn.2016.37","article-title":"Pompe disease: diagnosis and management. Evidence-based guidelines from a Canadian expert panel","volume":"43","author":"Tarnopolsky","year":"2016","journal-title":"Can J Neurol Sci"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1367108\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T05:00:23Z","timestamp":1708405223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1367108\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":19,"alternative-id":["10.3389\/fcvm.2024.1367108"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1367108","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"article-number":"1367108"}}